SCHEMBL23383175

SCHEMBL23383175

CC(C)(C)OC(=O)c1ccccc1C(=O)OC1(C(F)(F)C(=O)O)CCCCC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA1A P35348 1/20 0.34
▸ ADRA1B P35368 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ HSD11B1 P28845 1/20 0.33
▸ SCN1A P35498 2/20 0.33
▸ SCN2A Q99250 2/20 0.33
▸ SCN3A Q9NY46 2/20 0.33
▸ FFAR4 Q5NUL3 1/20 0.32
▸ ADORA3 P0DMS8 1/20 0.31
▸ GRM6 O15303 1/20 0.31
▸ ALDH1A1 P00352 3/20 0.31
▸ TDP1 Q9NUW8 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ TACR1 P25103 1/20 0.30
▸ RORC P51449 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23383176 0.86 SCN1A (0.43) HSD11B1SCN1ASCN2ASCN3AFFAR4
SCHEMBL23383170 0.85 CA12 (0.38) ADORA3ALDH1A1TDP1TSHRHSD17B10
SCHEMBL6906600 0.78 TSHR (0.38) HSD11B1SCN1ASCN2ASCN3AALDH1A1
SCHEMBL23382838 0.76 ELANE (0.49) ADORA3ALDH1A1TDP1
SCHEMBL23382835 0.75 ADORA3 (0.43) ADORA3ALDH1A1TSHRHSD17B10LMNA
Hydrogen Peroxide SCHEMBL29048859 0.74 TSHR (0.48) ADRA1AADRA1BGRM6ALDH1A1TDP1
SCHEMBL23383172 0.73 CYP19A1 (0.37) SCN1ASCN2ASCN3AADORA3ALDH1A1
SCHEMBL23382490 0.72 SCN1A (0.43) ACHEHSD11B1SCN1ASCN2ASCN3A
SCHEMBL109178 0.72 TSHR (0.50) ADRA1AADRA1BGRM6ALDH1A1TDP1
SCHEMBL30111657 0.72 TSHR (0.50) ADRA1AADRA1BGRM6ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process IDUA, SLC6A5, SLC6A9 ADRA1A 3858/4885ADRA1B 3649/4885ACHE 4522/4885
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS IDUA, SLC6A5, SLC6A9 ADRA1A 3858/4885ADRA1B 3649/4885ACHE 4522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback